Fecal bile acid excretion profile in gallstone patients

Medicina

Volumn 59, Issue 3, 1999, Pages 269-273

  Mamianetti, Arnaldo ^a   Garrido, Delia ^b   Carducci, Clyde Nora ^b   Vescina, Maria Cristina ^b  

^a Hospital Aeronautico Central   (Argentina)

^b NONE

Author keywords

Fecal bile acids; Gallstones; HPLC

Indexed keywords

BILE ACID;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHEMISTRY; CHOLELITHIASIS; COLON TUMOR; FECES; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED;

ADULT; ANALYSIS OF VARIANCE; BILE ACIDS AND SALTS; CHOLELITHIASIS; COLONIC NEOPLASMS; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0041706839     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Breuer NF, Katschinski B, Mörtl E, Leder L-D, Goebell H. Large bowel cancer risk in cholelithiasis and after cholecystectomy. Digestion 1988; 40: 219-26.
2. Jørgensen T, Rafaelsen S. Gallstone and colectal cancer. There is a relationship, but it is hardly due cholecystectomy. Dis Colon Rectum 1992; 35: 24-8.
3. McFarlane MJ, Welch KE. Gallstones, cholecystectomy, and colorectal cancer. Am J Gastroenterol 1993; 88: 1994-9.
4. Castleden WM, Doouss TW, Jennings KP, Leighton M. Gallstones, carcinoma of the colon and diverticular disease. Clin Oncol 1978; 4: 139-44.
5. Mercer PM, Reid FDA, Harrison M, Bates T. The relationship between cholecystectomy, unoperated gallstone disease, and colorectal cancer. Scand J Gastroenterol 1995; 30: 1017-20.
6. Lowenfels AB, Domellöf L, Lindström CG, Bergmam F, Monk MA, Sternby NH. Cholelithiasis, cholecystectomy, and cancer: a case-control study in Sweden-Gastroenterology 1982; 83: 672-6.
7. Linos DA, O'Fallon WM, Thistle JL, Kurland LT. Cholelithiasis and carcinoma of the colon. Cancer 1982; 50: 1015-9.
8. Den Besten L, Connor WE, Bell S. The effect of dietary cholesterol on the composition of human bile. Surgery 1973; 73: 266-73.
9. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990, 323: 1664-72.
10. White BA, Lipsky RL, Fricke RJ, Hylemon PB. Bile acid induction specificity of 7α-dehydroxylase activity in an intestinal Eubacterium species. Steroids 1980; 35: 103-9.
11. Reddy BS, Wynder EL. Large-bowel carcinogenesis: fecal constituents of population with diverse incidence rates of colon cancer. J Natl Cancer Inst 1973; 50: 1437-42.
12. Moorehead RJ, McKelvey STD. Cholecystectomy and colorectal cancer. Br J Surg 1989; 76: 250-3.
13. Hill MJ, Drasar BS, Williams REO, et al. Fecal bile acids and clostridia in patients with cancer of the large bowel. Lancet 1975; i: 535-9.
14. McMichael AJ, Potter JD. Host factors in carcinogenesis: Certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 1985; 75: 185-91.
15. Mudd DG, McKelvey STD, Norwood W, Elmore DT, Roy AD. Fecal bile acid concentrations of patients with carcinoma of increased risk of carcinoma in the large bowel. Gut 1980; 21: 587-90.
16. Vescina MC, Mamianetti A, Vizioli NM, et al. Evaluation of fecal bile acid profiles by HPLC after using disposable solid phase columns. J Pharmacol Biomed Analysis 1993; 16/11: 1331-5.
17. Carducci CN, Matejka M, Erguven H, Labonia N, Mamianetti A. High-performance liquid Chromatographic analysis of bile acids in hamster bile. J Chromatogr 1985; 337: 91-7.
18. Siegel S. Nonparametric statistics. In: The Behavioral Sciences. Tokyo: Kogakusha Ltd., 1959: 184-94.
19. Podesta MT, Murphy GM, Sladen GE, Breuer NF, Dowling RH. Fecal bile acid excretion in diarrhea: effect of sulfated and non-sulfated bile acids on colonic structure and function. In: Paumgartner G., Stiehl A., Gerok W (eds). Biological effects of bile acid. Lancaster: M.T.P. Press 1979; 245-56.
20. Setchell KDR, Ives JA, Cashmore GC, Lawson AM. On the homogenicity of stools with respect to bile acid composition and normal day-to-day variations: a detailed qualitative and quantitative study using capillary column gas chromatography-mass spectrometry. Clin Chim Acta 1987; 162: 257-74.
21. Setchell KDR, Lawson AM, Tanida N, Sjovall J. General methods for the analysis metabolic profiles of bile acids and related compounds in feces. J Lipid Res 1983; 24: 1085-1100.
22. Ferguson LR, Parry JM. Mitotic aneuploidy as a possible mechanism for tumor promoting activity in bile acids. Carcinogenesis 1984; 5: 447-52.
23. Roda E, Cipolla A, Bazzoli F, Villanova N, Mazzella G, Roda A. Modification in biliary lipid secretion and bile acid kinetics in the pathogenesis of cholesterol gallstones. In: Fromm H, Leuschner U (eds). Bile acid-cholestasis-gallstones. Dordrecht: Kluwer Academic Publishers, 1966; 176-9.
24. Heaton KW, Emmett PM, Symes CL, Braddon FEM. An explanation for gallstones in normal-weight women: slow intestinal transit. Lancet 1993; 341-8-10.
25. Fedorowski T, Salen G, Colallilo A, Tint GS, Mosbach EH, Hall JC. Metabolism of ursodeoxycholic acid in man. Gastroenterology 1977; 73: 1131-7.
26. Fromm H, Carlson GL, Hofmann AF, Farivar S, Amin P. Metabolism in man of 7-ketolithocholic acid: precursor of cheno and ursodeoxycholic acids. Am J Physiol 1980; 239: G 161-G 6.
27. Owen RW, Dodo M, Thompson MH, Hll Mj. Fecal steroids and colorectal cancer. Nutr Cancer 1987; 9: 73-80.
28. Nair PP, Gordon M, Reback J. The enzymatic cleavage of the carbon-nitrogen bond in 3α, 7α, 12α-trihydroxy-5β-cholan 24-oyl glycine. J Biol Chem 1967; 242: 7-11.
29. Ferguson LR, Rewcastle GW, Lello JM, Alley PG, Seelye PG. Quantitation of free and conjugated bile acids in human feces using a High-Pressure Liquid Chromatography counterion method. Anal Biochem 1984; 143: 325-32.
30. Heuman DM, Bajaj R. Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. Gastroenterology 1994; 106: 1333-41.
31. Wilpart M. Co-mutagenicity of bile acids: structure-activity relations. Eur J Cancer Prev 1991; 1 (supp 2): 45-8.